Genetic Modifier Screening
Genetic Modifier Screening is a phenotypic screening strategy that identifies genetic variants capable of altering the expression or severity of a specific phenotype, thereby distinguishing itself from other screening approaches by focusing on modifier genes that influence the phenotypic outcomes of primary mutations.
34
Publications
1.6K
Citations
233
Authors
82
Institutions
Publications per year
2017–2026
12
Variants
Genetic Modifier Screens
Parents
34
Hannes E. Bülow, Katherine L. Berry, Liat H. Topper et al. · Proceedings of the National Academy of Sciences · 2002 · 164 citations · Full text
Frauke Coppieters, Ingele Casteels, Françoise Meire et al. · Human Mutation · 2010 · 146 citations · Full text
Chemical Genetic Modifier Screens
Kathryn M. Koeller, Stephen J. Haggarty, Brian D. Perkins et al. · Chemistry & Biology · 2003 · 90 citations · Full text
1–5 of 34
233
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 233
82

Howard Hughes Medical Institute
Chevy Chase, United States
4 h-index
11 publications
1.7K citations
Harvard University
Cambridge, United States
3 h-index
18 publications
2.1K citations
Mayo Clinic in Arizona
Scottsdale, United States
2 h-index
5 publications
123 citations
Yale University
New Haven, United States
2 h-index
12 publications
298 citations

Ghent University Hospital
Ghent, Belgium
2 h-index
11 publications
1.4K citations
KU Leuven
Leuven, Belgium
2 h-index
10 publications
420 citations
University of Michigan
Ann Arbor, United States
2 h-index
4 publications
71 citations

Salk Institute for Biological Studies
La Jolla, United States
2 h-index
7 publications
409 citations
1–8 of 82
8 publications · 291 citations
8
h-index
PNAS · 3 publications · 194 citations
3
h-index
2 publications · 32 citations
2
h-index
2 publications · 168 citations
2
h-index
1 publications · 21 citations
1
h-index
1–5